Media , NEWS
2021.10.22
Rebirthel was featured on Nihon Keizai Shimbun (Japanese newspaper)
In the morning edition of Nihon Keizai Shimbun on October 22nd, 2021 (Page 18, Technology), Rebirthel’s research and development activity was introduced. In the article entitled “iPS cell technology reduces cancer treatment cost”, Rebirthel is mentioned as one of the leading companies developing cancer immune therapy using iPS cells. It is introduced that the technology to produce killer T cell from iPS cell, which kill cancers, is based on the methods developed by Professor Hiroshi Kawamoto, an executive director of Rebirthel.
Link to the article (Available to members and only in Japanese)
https://www.nikkei.com/article/DGXZQOUC161XE0W1A410C2000000/